China Shineway Pharmac.Grp Logo
KYG2110P1000
A0DNLW
2877.HK

China Shineway Pharmac.Grp

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, China Shineway Pharmac.Grp has already paid €0.26 in dividends. The last payout was in October.

Financials

In the last quarter, China Shineway Pharmac.Grp had revenue of €150.22M and net profit of €59.67M
(EUR) June 2026
YoY
Revenue 150.22M -
Gross profit 105.01M -
Net profit 59.67M -
EBITDA 52.31M -

Fundamentals

Metric Value
Market capitalization
€664.2M
Number of shares
755.4M
52-week high/low
€1.21 - €0.82
Dividend yield
30.80%
Dividends TTM
€0.27
Beta
0.68
P/E ratio
6.15
PEG ratio
-1.68
P/B ratio
0.59
P/S ratio
1.84

Company profile

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.

Name
China Shineway Pharmac.Grp
CEO
Zhenjiang Li
Headquarters Shijiazhuang, he
Cayman Islands
Website
IPO
12/02/2004
Employees 2,656

Ticker symbols

Exchange Symbol
Hkse
2877.HK
Pnk
CSWYF
Frankfurt
C1S.F
München
C1S.MU
Düsseldorf
C1S.DU
🍪

Parqet  uses cookies. Learn more